660KRW
5.59 BKRW
15.59 BKRW
4.42 M
About BIO-FD&C
Sector
Industry
Headquarters
Inchon
Website
Employees (FY)
72
Founded
2005
FIGI
BBG0149KH7V8
Bio-FD&C Co., Ltd. engages in the development of bio and health technologies. Its products include vegetable cells, peptides, biomolecule, natural extract, and others. The company was founded on November 11, 2005 and is headquartered in Incheon, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 251120 is 14000 KRW — it has decreased by 0.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BIO-FD&C stocks are traded under the ticker 251120.
251120 stock is 2.90% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is BIO-FD&C there?
BIO-FD&C revenue for the last quarter amounts to 3.30 B KRW despite the estimated figure of 4.60 B KRW. In the next quarter revenue is expected to reach 3.80 B KRW.
Yes, you can track BIO-FD&C financials in yearly and quarterly reports right on TradingView.
251120 stock has risen by 1.97% compared to the previous week, the month change is a 9.72% rise, over the last year BIO-FD&C has showed a 14.95% decrease.
251120 net income for the last quarter is 2.35 B KRW, while the quarter before that showed 1.14 B KRW of net income which accounts for 105.76% change. Track more BIO-FD&C financial stats to get the full picture.
Today BIO-FD&C has the market capitalization of 119.41 B, it has decreased by 5.70% over the last week.
No, 251120 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 251120 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-FD&C stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 72.00 employees. See our rating of the largest employees — is BIO-FD&C on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO-FD&C technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO-FD&C stock shows the neutral signal. See more of BIO-FD&C technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-FD&C EBITDA is 6.13 B KRW, and current EBITDA margin is 39.26%. See more stats in BIO-FD&C financial statements.